Literature DB >> 33136717

State Scope of Practice Laws: An Analysis of Physician Assistant Programs and Graduates.

Virginia L Valentin1,2,3,4, Shahpar Najmabadi1,2,3,4, Jeffery Jones1,2,3,4, Christine M Everett1,2,3,4.   

Abstract

PURPOSE: The purpose of this study was to understand the association between physician assistant (PA) state scope of practice (SOP) laws and (1) PA program growth and (2) PA graduate demographics.
METHODS: Scope of practice laws were categorized as ideal, average, and restrictive. Descriptive statistics by year and SOP categories were determined for the number of states, population density, PA programs, and PA graduate number, gender, race, and mean age. The Mann-Whitney U test was used to analyze demographic data by SOP categories. Adjusted risk ratios were generated for the number of PA programs and SOP categories.
RESULTS: The number of PA programs is not associated with ideal SOP states. As of 2017, only 10 states have restrictive SOP laws. A minority of PA students now graduate from states with restrictive SOP laws.
CONCLUSION: There is heterogeneity in PA SOP laws throughout the United States but only a minority of PA graduates now come from restrictive SOP states. This study provides foundational information prior to the implementation of optimal team practice.

Year:  2020        PMID: 33136717     DOI: 10.1097/JPA.0000000000000331

Source DB:  PubMed          Journal:  J Physician Assist Educ        ISSN: 1941-9430


  2 in total

1.  Cross-sectional analysis of US scope of practice laws and employed physician assistants.

Authors:  Virginia L Valentin; Shahpar Najmabadi; C Everett
Journal:  BMJ Open       Date:  2021-05-11       Impact factor: 2.692

2.  Maximizing Black applicant matriculation in U.S. PA programs: associations between the number of submitted applications and likelihood of matriculation.

Authors:  Trenton Honda; Trenton D Henry; Ellen D Mandel; Alicia Quella; José E Rodríguez; Shahpar Najmabadi; Virginia L Valentin
Journal:  BMC Med Educ       Date:  2021-02-23       Impact factor: 2.463

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.